Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Secondary Lymphoid Organs01:15

Secondary Lymphoid Organs

Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ibrutinib plus venetoclax for relapsed/refractory mantle cell lymphoma: Final analysis of the phase 3 SYMPATICO study.

British journal of haematology·2026
Same author

Short ramp-up glofitamab halves mortality risk after anti-CD19 CAR T-cell therapy failure in patients with diffuse large B-cell lymphoma: final results of the LYSA BiCAR phase 2 trial with a pre-specified external control arm.

Journal of hematology & oncology·2026
Same author

Role of radiotherapy in refractory/relapsed classical Hodgkin lymphoma in the era of targeted therapies and immunotherapy.

Clinical and translational radiation oncology·2026
Same author

Epcoritamab monotherapy or epcoritamab with lenalidomide as first-line therapy for patients with diffuse large B-cell lymphoma (EPCORE DLBCL-3): primary analysis of an open-label, multicentre, randomised, phase 2 trial.

The Lancet. Haematology·2026
Same author

Outcomes of critically ill patients with newly diagnosed Burkitt's lymphoma: a monocentric retrospective study.

Annals of intensive care·2026
Same author

Integrated multi-omic profiling reveals two distinct splenic marginal zone lymphoma subgroups with prognostic relevance.

Blood advances·2026

Related Experiment Video

Updated: Jun 1, 2026

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

Non-MALT marginal zone lymphoma.

Catherine Thieblemont1, Frederic Davi, Maria-Elena Noguera

  • 1Department of Hemato-Oncology, AP-HP Hôpital Saint-Louis, Laboratoire de Pathologie, Université Paris Diderot, Sorbonne Paris Cité, UMR-S 728, France. catherine.thieblemont@sls.aphp.fr

Current Opinion in Hematology
|May 18, 2011
PubMed
Summary

Splenic marginal zone lymphoma (SMZL) and nodal marginal zone lymphoma (NMZL) are distinct non-MALT lymphomas. Recent findings highlight differences in clinical presentation, diagnosis, and therapeutic strategies for these conditions.

More Related Videos

Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma
08:31

Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma

Published on: September 12, 2025

Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation
07:17

Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation

Published on: August 23, 2024

Related Experiment Videos

Last Updated: Jun 1, 2026

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma
08:31

Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma

Published on: September 12, 2025

Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation
07:17

Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation

Published on: August 23, 2024

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Background:

  • Non-MALT marginal zone lymphomas encompass splenic marginal zone lymphoma (SMZL) and nodal marginal zone lymphoma (NMZL).
  • These lymphomas originate from the marginal zone but exhibit distinct clinical behaviors, suggesting organ-specific biological variations.

Purpose of the Study:

  • To review current knowledge on the biological findings, clinical features, and therapeutic approaches for SMZL and NMZL.
  • To highlight recent advances in understanding pathogenic mechanisms and treatment strategies.

Main Methods:

  • Comprehensive literature review of recent data on SMZL and NMZL.
  • Analysis of diagnostic criteria and therapeutic outcomes.

Main Results:

  • SMZL and NMZL often present with disseminated disease, characterized by splenomegaly (SMZL) or nodal involvement (NMZL).
  • Diagnostic criteria have been recently improved due to challenges in differentiating these small B-cell lymphomas.
  • Therapeutic options include splenectomy for SMZL and immunochemotherapy for both, with ongoing debate on optimal treatment, particularly in hepatitis C virus-associated cases.

Conclusions:

  • SMZL and NMZL, despite a common origin, possess unique clinical and pathological characteristics.
  • Improved diagnostic criteria and evolving therapeutic strategies are crucial for managing these distinct lymphoma subtypes.
  • Further research is needed to establish consensus on the best treatment protocols for SMZL and NMZL.